<DOC>
	<DOCNO>NCT00358176</DOCNO>
	<brief_summary>To confirm non-inferiority 75 mg risedronate tablet take 2 consecutive day per month compare 5 mg risedronate tablet take daily increase bone mass lumbar spine postmenopausal woman osteoporosis . To confirm efficacy 75 mg risedronate tablet take 2 consecutive day per month postmenopausal woman osteoporosis increase bone mass proximal femur , femoral neck femoral trochanter decrease bone resorption . To confirm general safety 75 mg risedronate tablet take 2 consecutive day per month compare 5 mg risedronate take daily .</brief_summary>
	<brief_title>Risedronate 75mg Dosed 2 Consecutive Days Monthly Treatment Osteoporosis Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<mesh_term>Etidronic Acid</mesh_term>
	<criteria>Subjects meet follow criterion consider enrollment study : ·Ambulatory , healthy postmenopausal woman : Natural menopause 5 year last menstrual period . Or surgical menopause 5 year surgery ( blood hormone test require subject less 65 year age uterus remove without removal ovary time surgery ) . Osteoporosis ( lumbar spine Tscore 2.5 SD mean value normal young woman 2.0 SD mean value normal young woman least 1 fracture vertebra ( thoraciclumbar T4L4 ) ) . Subjects follow criterion consider enrollment study : ·Women receive hormone replacement therapy ( estrogen mouth and/or progestogen and/or androgen ) raloxifene , bone active drug , calcitonin , calcitriol/calcidiol/alfacalcidol , parathyroid hormone bisphosphonate within 3 month first dose study medication .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Treatment osteoporosis postmenopausal</keyword>
</DOC>